Promoting and facilitating strategies to improve cardiovascular health worldwide

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



Genetic variant that causes vegetables to taste bitter makes heart-healthy diet challenging for some

Posted on November 17, 2019

PHILADELPHIA — People with a gene variant that makes certain vegetables taste bitter had lower vegetable intake compared with people without the... more

DAPA-HF: Dapagliflozin’s HF benefits consistent regardless of age, symptom severity

Posted on November 17, 2019

PHILADELPHIA — Treatment with the SGLT2 inhibitor dapagliflozin reduced risk for CV death and worsening HF across a broad spectrum of age,... more

COMPLETE OCT: Nearly half of patients with obstructive nonculprit lesions have vulnerable plaque

Posted on November 17, 2019

PHILADELPHIA — In an OCT substudy of the COMPLETE trial, researchers determined that 47% of patients had obstructive nonculprit lesions with vulnerable... more

PARAGON-HF: Sacubitril/valsartan benefit in HFpEF most prominent in women, lower EF

Posted on November 17, 2019

PHILADELPHIA — Sacubitril/valsartan reduced the risk for HF hospitalization more in women compared with men, and the overall benefit of sacubitril/valsartan was... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  •  Augusto Gallino


    Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX (more…) more

  •  Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  •  Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  •  Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more